XML 60 R53.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue and Segment Information - Summary of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Total revenue $ 143,537 $ 96,850
Total cost of revenue 55,309 36,888
Research, development and clinical trials:    
Research, development and clinical trials 17,160 11,380
Selling, general and administrative:    
Selling, general and administrative 43,625 36,161
Other segment items [1] 1,761 224
Net income 25,682 12,197
Cost of Net Product Revenue [Member]    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Total revenue 88,234 61,325
Total cost of revenue 16,312 14,084
Cost of Service Revenue [Member]    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Total revenue 55,303 35,525
Total cost of revenue 38,997 22,804
Personnel related (including stock-based compensation expense)    
Research, development and clinical trials:    
Research, development and clinical trials 6,252 5,264
Selling, general and administrative:    
Selling, general and administrative 27,671 24,387
Laboratory supplies and research materials    
Research, development and clinical trials:    
Research, development and clinical trials 4,956 2,314
Consulting and third-party services    
Research, development and clinical trials:    
Research, development and clinical trials 4,173 2,007
Clinical trials costs    
Research, development and clinical trials:    
Research, development and clinical trials 81 82
Professional and consultant fees    
Selling, general and administrative:    
Selling, general and administrative 7,558 3,765
NOP support    
Selling, general and administrative:    
Selling, general and administrative 2,406 1,962
Tradeshows and conferences    
Selling, general and administrative:    
Selling, general and administrative 426 983
Facility related and other    
Research, development and clinical trials:    
Research, development and clinical trials 1,698 1,713
Selling, general and administrative:    
Selling, general and administrative $ 5,564 $ 5,064
[1] Other segment items include interest income, interest expense, foreign currency exchange gains and losses and income taxes. See the condensed consolidated financial statements for other financial information regarding the Company’s operating segment.